Aqueous extract of Paris polyphylla (AEPP) inhibits ovarian cancer via suppression of peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha

Chia Woei Wang, Cheng Jeng Tai, Chen Yen Choong, Yu Chun Lin, Bao Hong Lee, Yeu Ching Shi, Chen Jei Tai

研究成果: 雜誌貢獻文章

8 引文 (Scopus)

摘要

Chemotherapy, a major approach was used in carcinoma treatment, always involves the development of drug resistance as well as side-effects that affect the quality of patients' lives. An association between epithelial-mesenchymal transition (EMT) and chemotherapy resistance was established recently. We demonstrate in this paper that the aqueous extract of Paris polyphylla (AEPP) - a traditional Chinese medicine - can be used in various cancer types for suppression of carcinogenesis. We evaluated the suppressions of EMT and mitochondrial activity by AEPP treatment in a high-glucose (HG) induced-human ovarian carcinoma cell line (OVCAR-3 cells). The mitochondrial morphology was investigated using MitoTracker Deep Red FM staining. Our results indicated that AEPP reduced the viability of OVCAR-3 cells considerably through induction of apoptosis. However, this inhibitory potential of AEPP was attenuated by HG induction in OVCAR-3 cells. The levels of estrogen-related receptor (ERR)-alpha activator and peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha were elevated by HG induction, but were suppressed by AEPP treatment. Down-regulations of cell survival and EMT were oberved in OVCAR-3 cells through suppression of PGC-1alpha by AEPP treatment. These results were confirmed through PGC-1alpha knockdown and overexpression in OVCAR-3 cells. Thus, AEPP can be beneficial for treating ovarian cancer and has potential for development of an integrative cancer therapy against ovarian cancer proliferation, metastasis, and migration.

原文英語
文章編號727
期刊Molecules
21
發行號6
DOIs
出版狀態已發佈 - 六月 1 2016

指紋

PPAR gamma
Paris
Ovarian Neoplasms
Chemotherapy
cancer
retarding
Glucose
Epithelial-Mesenchymal Transition
Cells
glucose
cells
induction
chemotherapy
Medicine
Apoptosis
estrogens
Carcinoma
Therapeutics
Drug Therapy
apoptosis

ASJC Scopus subject areas

  • Organic Chemistry

引用此文

Aqueous extract of Paris polyphylla (AEPP) inhibits ovarian cancer via suppression of peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha. / Wang, Chia Woei; Tai, Cheng Jeng; Choong, Chen Yen; Lin, Yu Chun; Lee, Bao Hong; Shi, Yeu Ching; Tai, Chen Jei.

於: Molecules, 卷 21, 編號 6, 727, 01.06.2016.

研究成果: 雜誌貢獻文章

@article{437ff6ee73334c81a5ce5420cfa35f0c,
title = "Aqueous extract of Paris polyphylla (AEPP) inhibits ovarian cancer via suppression of peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha",
abstract = "Chemotherapy, a major approach was used in carcinoma treatment, always involves the development of drug resistance as well as side-effects that affect the quality of patients' lives. An association between epithelial-mesenchymal transition (EMT) and chemotherapy resistance was established recently. We demonstrate in this paper that the aqueous extract of Paris polyphylla (AEPP) - a traditional Chinese medicine - can be used in various cancer types for suppression of carcinogenesis. We evaluated the suppressions of EMT and mitochondrial activity by AEPP treatment in a high-glucose (HG) induced-human ovarian carcinoma cell line (OVCAR-3 cells). The mitochondrial morphology was investigated using MitoTracker Deep Red FM staining. Our results indicated that AEPP reduced the viability of OVCAR-3 cells considerably through induction of apoptosis. However, this inhibitory potential of AEPP was attenuated by HG induction in OVCAR-3 cells. The levels of estrogen-related receptor (ERR)-alpha activator and peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha were elevated by HG induction, but were suppressed by AEPP treatment. Down-regulations of cell survival and EMT were oberved in OVCAR-3 cells through suppression of PGC-1alpha by AEPP treatment. These results were confirmed through PGC-1alpha knockdown and overexpression in OVCAR-3 cells. Thus, AEPP can be beneficial for treating ovarian cancer and has potential for development of an integrative cancer therapy against ovarian cancer proliferation, metastasis, and migration.",
keywords = "Epithelial-mesenchymal transition (EMT), High glucose induction, Ovarian cancer, Paris polyphylla, Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha",
author = "Wang, {Chia Woei} and Tai, {Cheng Jeng} and Choong, {Chen Yen} and Lin, {Yu Chun} and Lee, {Bao Hong} and Shi, {Yeu Ching} and Tai, {Chen Jei}",
year = "2016",
month = "6",
day = "1",
doi = "10.3390/molecules21060727",
language = "English",
volume = "21",
journal = "Molecules",
issn = "1420-3049",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - Aqueous extract of Paris polyphylla (AEPP) inhibits ovarian cancer via suppression of peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha

AU - Wang, Chia Woei

AU - Tai, Cheng Jeng

AU - Choong, Chen Yen

AU - Lin, Yu Chun

AU - Lee, Bao Hong

AU - Shi, Yeu Ching

AU - Tai, Chen Jei

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Chemotherapy, a major approach was used in carcinoma treatment, always involves the development of drug resistance as well as side-effects that affect the quality of patients' lives. An association between epithelial-mesenchymal transition (EMT) and chemotherapy resistance was established recently. We demonstrate in this paper that the aqueous extract of Paris polyphylla (AEPP) - a traditional Chinese medicine - can be used in various cancer types for suppression of carcinogenesis. We evaluated the suppressions of EMT and mitochondrial activity by AEPP treatment in a high-glucose (HG) induced-human ovarian carcinoma cell line (OVCAR-3 cells). The mitochondrial morphology was investigated using MitoTracker Deep Red FM staining. Our results indicated that AEPP reduced the viability of OVCAR-3 cells considerably through induction of apoptosis. However, this inhibitory potential of AEPP was attenuated by HG induction in OVCAR-3 cells. The levels of estrogen-related receptor (ERR)-alpha activator and peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha were elevated by HG induction, but were suppressed by AEPP treatment. Down-regulations of cell survival and EMT were oberved in OVCAR-3 cells through suppression of PGC-1alpha by AEPP treatment. These results were confirmed through PGC-1alpha knockdown and overexpression in OVCAR-3 cells. Thus, AEPP can be beneficial for treating ovarian cancer and has potential for development of an integrative cancer therapy against ovarian cancer proliferation, metastasis, and migration.

AB - Chemotherapy, a major approach was used in carcinoma treatment, always involves the development of drug resistance as well as side-effects that affect the quality of patients' lives. An association between epithelial-mesenchymal transition (EMT) and chemotherapy resistance was established recently. We demonstrate in this paper that the aqueous extract of Paris polyphylla (AEPP) - a traditional Chinese medicine - can be used in various cancer types for suppression of carcinogenesis. We evaluated the suppressions of EMT and mitochondrial activity by AEPP treatment in a high-glucose (HG) induced-human ovarian carcinoma cell line (OVCAR-3 cells). The mitochondrial morphology was investigated using MitoTracker Deep Red FM staining. Our results indicated that AEPP reduced the viability of OVCAR-3 cells considerably through induction of apoptosis. However, this inhibitory potential of AEPP was attenuated by HG induction in OVCAR-3 cells. The levels of estrogen-related receptor (ERR)-alpha activator and peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha were elevated by HG induction, but were suppressed by AEPP treatment. Down-regulations of cell survival and EMT were oberved in OVCAR-3 cells through suppression of PGC-1alpha by AEPP treatment. These results were confirmed through PGC-1alpha knockdown and overexpression in OVCAR-3 cells. Thus, AEPP can be beneficial for treating ovarian cancer and has potential for development of an integrative cancer therapy against ovarian cancer proliferation, metastasis, and migration.

KW - Epithelial-mesenchymal transition (EMT)

KW - High glucose induction

KW - Ovarian cancer

KW - Paris polyphylla

KW - Peroxisome proliferator-activated receptor-gamma coactivator (PGC)-1alpha

UR - http://www.scopus.com/inward/record.url?scp=84976601771&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976601771&partnerID=8YFLogxK

U2 - 10.3390/molecules21060727

DO - 10.3390/molecules21060727

M3 - Article

C2 - 27271583

AN - SCOPUS:84976601771

VL - 21

JO - Molecules

JF - Molecules

SN - 1420-3049

IS - 6

M1 - 727

ER -